Literature DB >> 11272876

The Short Form 36 (SF-36) Health Survey: normative data for the Irish population.

C Blake1, M B Codd, Y M O'Meara.   

Abstract

BACKGROUND: Generic measures of quality of life have a wide application in health research. They measure disease impact by comparing scores in patient groups with a healthy population. They also facilitate comparative studies between different patient groups. The SF-36 Health Survey quantifies respondents' perceptions of their functioning in eight dimensions of daily life. AIM: The aim of this study was to set normative values for the SF-36 in the Irish population aged 18 years and over.
METHOD: A random sample of 800 subjects was drawn from the electoral register using the RANSAM method of sampling.
RESULTS: Two hundred and ninety five (37%) valid questionnaires were returned for analysis. The SF-36 was found to have acceptable internal consistency and validity. Normative values for the total population are presented, in addition to results for males and females across seven age groups. Ageing was associated with a decline in the physical dimensions of health.
CONCLUSIONS: There was no evidence to suggest that there were significant differences in health status between males and females, or between this Irish sample and the published norms for the US population.

Entities:  

Mesh:

Year:  2000        PMID: 11272876     DOI: 10.1007/bf03167695

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  17 in total

1.  Time-limit tests: estimating their reliability and degree of speeding.

Authors:  L J CRONBACH; W G WARRINGTON
Journal:  Psychometrika       Date:  1951-06       Impact factor: 2.500

2.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Test-retest performance of a mailed version of the Medical Outcomes Study 36-Item Short-Form Health Survey among older adults.

Authors:  E M Andresen; N Bowley; B M Rothenberg; R Panzer; P Katz
Journal:  Med Care       Date:  1996-12       Impact factor: 2.983

4.  Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial.

Authors:  K N Lohr; R H Brook; C J Kamberg; G A Goldberg; A Leibowitz; J Keesey; D Reboussin; J P Newhouse
Journal:  Med Care       Date:  1986-09       Impact factor: 2.983

5.  Bias in analytic research.

Authors:  D L Sackett
Journal:  J Chronic Dis       Date:  1979

6.  Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey.

Authors:  C A McHorney; M Kosinski; J E Ware
Journal:  Med Care       Date:  1994-06       Impact factor: 2.983

7.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Authors:  C A McHorney; J E Ware; J F Lu; C D Sherbourne
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

Review 8.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

9.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

10.  Patients' perception of health on renal replacement therapy: evaluation using a new instrument.

Authors:  I H Khan; A M Garratt; A Kumar; D J Cody; G R Catto; N Edward; A M MacLeod
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

View more
  21 in total

1.  SF-36 normative values according to level of functioning in older women.

Authors:  Geeske Peeters; Michael Waller; Annette J Dobson
Journal:  Qual Life Res       Date:  2018-12-03       Impact factor: 4.147

2.  Measuring population mental health and social well-being.

Authors:  Eric Van Lente; Margaret M Barry; Michal Molcho; Karen Morgan; Dorothy Watson; Janas Harrington; Hannah McGee
Journal:  Int J Public Health       Date:  2011-11-03       Impact factor: 3.380

Review 3.  The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12. A systematic review.

Authors:  Johanna M van der Waal; Caroline B Terwee; Daniëlle A W M van der Windt; Lex M Bouter; Joost Dekker
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

4.  Prevalence of lymphoedema and quality of life among patients attending a hospital-based wound management and vascular clinic.

Authors:  Georgina Gethin; Danielle Byrne; Sean Tierney; Helen Strapp; Seamus Cowman
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

5.  Operationalizing Substantial Reduction in Functioning Among Young Adults with Chronic Fatigue Syndrome.

Authors:  Kristen D Gleason; Jamie Stoothoff; Damani McClellan; Stephanie McManimen; Taylor Thorpe; Ben Z Katz; Leonard A Jason
Journal:  Int J Behav Med       Date:  2018-08

6.  Examining the role of subjective and objective burden in carer health-related quality of life: the case of colorectal cancer.

Authors:  Paul Hanly; Rebecca Maguire; Philip Hyland; Linda Sharp
Journal:  Support Care Cancer       Date:  2014-12-12       Impact factor: 3.603

Review 7.  Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies.

Authors:  Cornelie D Andela; Margreet Scharloo; Alberto M Pereira; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

8.  Health-related quality of life of stroke survivors attending the volunteer stroke scheme.

Authors:  C Tobin; D Hevey; N F Horgan; R F Coen; C J Cunningham
Journal:  Ir J Med Sci       Date:  2008-02-02       Impact factor: 1.568

9.  Evaluation of conservative treatment of non specific spondylodiscitis.

Authors:  N Bettini; M Girardo; E Dema; S Cervellati
Journal:  Eur Spine J       Date:  2009-05-05       Impact factor: 3.134

10.  Assessing the impact of behavioral risk factors and known-groups validity of the SF-12 in a US Chinese immigrant population.

Authors:  Dorothy Y Hung; Erica I Lubetkin; Marianne C Fahs; Donna R Shelley
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.